Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

March 26, 2024

Shelby McMichael, Communications Manager

[email protected]


SACRAMENTO — The U.S. Supreme Court this morning heard oral arguments in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration – a case challenging the FDA’s approval and subsequent regulation of mifepristone, a drug used in combination with misoprostol in medication abortion. Medication abortion now accounts for over 60 percent of all abortion in the United States. The Court heard arguments on the FDA’s and Danco Laboratories’ (the pharmaceutical company that distributes mifepristone) petitions, which asked the Court to review the Fifth Circuit’s decision to reinstate restrictions on mifepristone that were in place pre-2016.

While the eventual decision issued by SCOTUS could result in a variety of outcomes, any outcome short of preserving full access to mifepristone would severely impact the provision of medication abortion in California, jeopardize the gains California has made toward equitable access to abortion, and ultimately have a devastating impact on pregnant people across the nation. A decision is expected in June.

Statement from Jodi Hicks, President/CEO of Planned Parenthood Affiliates of California:

“First and foremost, today’s Supreme Court hearing does not, for now, change access to or approval of mifepristone. Abortion medication remains legal and accessible in California. However, we must acknowledge that despite the work California has done to enshrine abortion as a constitutional right and enact robust protections for both patients and providers, the Supreme Court’s determination in this case could directly impact access to medication abortion in the state.

“Let’s be clear, this misguided, coordinated attack on mifepristone is part of the politically motivated campaign by anti-abortion extremists to realize a national abortion ban—a strong concern for most Californians.

“Despite the anti-abortion movement’s ongoing attacks on abortion care of all kinds, Planned Parenthood in California remains steadfast in our fight for reproductive freedom. While we await the Supreme Court’s decision in this case, and whatever the outcome may be, we will continue to affirm the belief held by a majority of Californians in the fundamental right to bodily autonomy and access to health care without barriers.”

Approval of and access to mifepristone remains unchanged until the Supreme Court issues a final decision, likely in June.

A Background Memo is available to reporters by request.



Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of our Necessary Cookies as they are deployed to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information, please see our Privacy Notice.



We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.



We use qualitative data, including session replay, to learn about your user experience and improve our products and services.



We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.